March 24, 2017

Biotechnology, Life Sciences, Food and Drug Law News

The National Law Review features a wide variety of content on issues important to life sciences companies, including biosimilars, biotechnology, medical devices, drug pricing, nanotechnology, and pharmaceuticals.  Our content reviews the impact the latest legal changes have on these industries, such as the 21st Century Cures Act. With all of these areas, our content covers issues such as licensing and patents, intellectual property, due diligence, litigation and tax implications.

We also have legal expertise on marketing compliance, licensing and collaborations, and bringing new products to market.  Additionally, the National Law Review is a source for all the latest legal news and regulatory compliance issues involving food and cosmetics safety and labeling requirements, activities of the Food and Drug Administration (“FDA”) and the US Department of Agriculture (“USDA”).

Date Title Organization
23
Mar
Medicinal Products: the EU and the US Mutually Recognize Manufacturing Standards K&L Gates
23
Mar
Congresswoman Calls for Halting Importation of Brazilian Meat Keller and Heckman LLP
23
Mar
FDA Grants One-Year Extension on Intended Use Rule Drinker Biddle & Reath LLP
22
Mar
SCCS Issues Final Opinion on Additional Coatings for Titanium Dioxide (Nano Form) as UV-Filter in Dermally Applied Cosmetic Products Bergeson & Campbell, P.C.
22
Mar
USDA Warns Canada-EU Trade Agreement Could Impact US Alcohol Beverage Exports McDermott Will & Emery
22
Mar
Even With History of Food Safety Disasters, Emails Show Perdue Fretted About Regulation MapLight
22
Mar
Senator Pat Roberts Urges Trump Administration to Scrap Reconsideration of COOL: Country of Origin Labeling Keller and Heckman LLP
22
Mar
Trump’s Ag Nominee Has Taken Almost $1 Million From Industry During Political Career MapLight
21
Mar
Wyden’s C-THRU Act – Publicizing PBM Drug Rebate Data Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
21
Mar
FDA May Simplify Produce Safety Rule’s Agricultural Water Standards Keller and Heckman LLP
21
Mar
Implications of EU Ingredient Labeling Proposal for US Suppliers McDermott Will & Emery
21
Mar
New Report Calls for Consistent Criteria to Identify EDCs Across All EU Laws Keller and Heckman LLP
20
Mar
Federal Appeals Court Upholds Dismissal of Public Employee For Failing Random Drug Test Jackson Lewis P.C.
20
Mar
Biologics Price Competition and Innovation Act Helps Amgen Gain Dismissal of Genentech Complaint Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
20
Mar
GNC Slack Fill Settlement Keller and Heckman LLP
20
Mar
Sonny Perdue to Testify Before Senate Agriculture Committee; USDA Funding Under President Trump’s “Skinny Budget” Squire Patton Boggs (US) LLP
18
Mar
NIOSH Will Hold Public Meeting and Seeks Comments on Draft CIB on the Occupational Exposure Banding Process: Guidance for the Evaluation of Chemical Hazards Bergeson & Campbell, P.C.
17
Mar
Drug Enforcement Administration Addition Of Marijuana Extracts To Schedule I Substance Category Sheds Light On The Ever-Expanding Arena Of Drugs In The Workforce Steptoe & Johnson PLLC
17
Mar
Neste Renewable Diesel Reduces GHG Emissions By 6.7 Million Tons Bergeson & Campbell, P.C.
17
Mar
FSIS Issues Updated Guidance Concerning Beef and Veal Slaughter Best Practices Keller and Heckman LLP

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS